Chennai: Health insurance claims for vector-borne diseases fell by nearly 20% in the previous year due to the emphasis on sanitation amid the pandemic. The sharp fall in these claims, which largely refer to mosquito-borne infections, come at a time when the insurance regulator Irdai has called for a standard cover for these cases, which include dengue, malaria, filaria, kala-azar, chikungunya, Japanese encephalitis and Zika virus.
Although the average claim size for vector-borne diseases is just Rs 35,000 — half of overall average health claim size of Rs 68,000 — they have a high prevalence in India. Irdai’s prescription is for a standard cover for these specific illnesses, which could be an add-on or a basic health cover
ICICI Lombard’ head of claims, Sanjay Datta says, “We saw a 10-20% YoY drop in health claims made for the treatment of vector borne disease category — especially dengue and typhoid- between April-December, 2020. This is primarily due to the fear of contracting coronavirus which drove everyone to keep their surroundings clean.” Bajaj Allianz General Insurance said the frequency of claims made for vector-borne diseases were at about 6% in 2019 and has come down to 4.6% in 2020. Its head of health claims Bhaskar Nerurkar said, “There is a 20% decline in claims made under vector-borne diseases. Hospital and treatment costs of these diseases are costlier after the Covid outbreak. We get maximum claims for treatment of dengue — over 50% of total claims.” After bringing in a standard health cover, Covid cover, and a term cover, the insurance regulator has released an exposure draft for a standard vector-borne disease health policy. General and health insurers are encouraged to offer this one-year cover, which will have a minimum sum assured of Rs 10,000 and a maximum of Rs 2 lakh.
More Stories
Suspension of Business Was Never Intended to Mean Total Cessation of Business Operations—Insurance Lawyers Duping Judges into Wrong Insurance Contract Interpretations
How Health Insurance Became America’s Biggest Hustle
Buffett optimistic on US, Berkshire Hathaway, buys back record US$24.7 billion of shares